![Nestlé Skin Health owns Galderma, a pharmaceutical company specialising in dermatological treatments, including Dysport (botox), which is being demonstrated at an event](https://s.wsj.net/public/resources/images/FN-AH129_fn_nes_M_20190516060942.jpg)
Evercore has landed a role advising Nestlé on the $10.1bn sale of its Skin Health business to a consortium of private equity firms, a boost to the company after a difficult first quarter for boutique investment banks.
The boutique bank is advising Nestlé alongside Credit Suisse on the transaction, with a group of private equity firms led by EQT and a subsidiary of the Abu Dhabi Investment Authority winning the fiercely contested deal.